The Monitoring of New Regulations SOP defines how regulatory updates are tracked, evaluated, and implemented to maintain continuous compliance.
It ensures your company stays aligned with evolving EMA, FDA, and ICH standards impacting GxP activities.
This SOP is fully written (≈ 98–99 % complete) and designed for biotech and life-science organizations managing multiple regulatory jurisdictions.
Includes:
•Regulatory intelligence and monitoring process
•Evaluation of new or updated guidelines
•Impact assessment and change implementation
•Responsibilities for QA, regulatory affairs, and management
•Documentation and communication of updates
A structured regulatory-monitoring process minimizes compliance gaps and keeps your QMS current at all times.